Top Insider Trades 7/3/13: NDLS, NVAX, VNR, OPK
Long/Short Equity, Insider Ownership, behavioral finance
Seeking Alpha Analyst Since 2012
Daily Top Insider Trades Instablog
- Did you know? You could have seen the trades below within hours of being filed. If you want more Top Trades emailed 4 times a day, sign up for our Free Intra-Day Top Trades Alerts.
In a victory for common sense, the trading behavior of company executives, directors, and large shareholders in the stocks of firms they're registered "insiders" at have been proven profitable to monitor by both academic studies and (more importantly) the experience of professional investors.
Below are lists of the top 10 mainly open-market insider purchases and sales filed at the Securities and Exchange Commission Wednesday, July 3, 2013 as ranked by dollar value.
Please note, however, that these are factual lists (with edits to remove some noise), not buy and sell recommendations. Dollar value is only one metric to assess the importance of an insider transaction, and, frankly, often not even the most important metric that determines if an insider transaction is significant.
We should also point out that we are presently in a slow filing time for insiders because many companies still have their trading windows closed to their executives until their June quarter earnings are released.
But at InsiderInsights.com, we find new investment ideas just about every day using these and more intricate insider screens to determine where we should focus our subsequent fundamental and technical analysis. And while stocks don't (or shouldn't) move up or down based on insider activity alone, insiders tend to be good indicators of when real stock-moving events like earnings surprises, corporate actions, and new products may be in the offing.
So use these regular blog posts as the initial research tools they are meant to be, and click the links in the tables to analyze a company's or insider's full insider history. Also feel free to email support@insiderinsights.com with any questions on our proprietary insider data, and how it is best analyzed.
| Filer Name | Insider Titles | Company Name | Ticker | Trans Type |
Dollar Value |
|---|---|---|---|---|---|
| Hottinger Capital | FO | Swiss Helvetia Fd | SWZ | B | $1,500,788 |
| Frost Phillip Md | CEO,CB,BO | Opko Health | OPK | B | $203,902 |
| Kinsey Keith J | PR,COO,DIR | Noodles | NDLS | JB* | $180,000 |
| Rand James T | DIR | Noodles | NDLS | JB* | $135,000 |
| Foster Vincent D | CEO,PR,DIR | Main Street Cap | MAIN | B,JB* | $101,204 |
| Phillips Barclay A | DIR | Novavax | NVAX | B | $95,000 |
| Petrilli Felix T | VP,OO | Noodles | NDLS | JB* | $90,000 |
| Robert Richard A | VP,CFO | Vanguard Nat Res | VNR | B | $51,520 |
| Smith Scott W | PR,CEO,DIR | Vanguard Nat Res | VNR | B | $50,500 |
| St Peter Steven | PR,CEO,DIR | Aratana Therap | PETX | JB* | $49,998 |
Source: InsiderInsights.com | Key to Insider Title and Trans Type Codes
| Filer Name | Insider Titles | Company Name | Ticker | Trans Type |
Dollar Value |
|---|---|---|---|---|---|
| Av Partners VIII | BO | Homeaway | AWAY | S | $31,577,610 |
| Fpr Partners | BO | Viasat | VSAT | S | $15,746,164 |
| Artiman | BO | Invensense | INVN | S | $7,397,164 |
| Gehring Fred | CEO,DIR | PVH | PVH | AS | $5,190,468 |
| FMR | BO | Insmed | INSM | S | $3,644,080 |
| Starzer Michael R | PR,CEO,DIR | Bonanza Crk En | BCEI | AS | $3,556,000 |
| Wicki Andreas | DIR | Pacira Pharm | PCRX | AS | $3,457,073 |
| Sze David L | DIR | LNKD | AS | $2,893,164 | |
| Auvil Paul R Iii | CFO | Proofpoint | PFPT | AS | $2,808,787 |
| Usrg Holdco V | BO | Ren Energy | REGI | AS | $2,724,774 |
Source: InsiderInsights.com | Key to Insider Title and Trans Type Codes
Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.